Edition:
United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.00USD
9 Dec 2016
Change (% chg)

$0.09 (+9.30%)
Prev Close
$0.92
Open
$0.94
Day's High
$1.19
Day's Low
$0.92
Volume
1,038,920
Avg. Vol
51,009
52-wk High
$3.52
52-wk Low
$0.85

Ross, George 

Mr. George K. Ross is Independent Director of Acura Pharmaceutical Technologies, Inc. since January, 2008. Since April 2002, Mr. Ross has been a consultant to early stage businesses and a financial investor. From July 2005 through December 2010 he served as Executive Director, Foundations and Partnerships for World Vision U.S. in New York City. His business career has included senior financial officer and board member positions with both public and private companies in diverse industries. Mr. Ross was Executive Vice President and Chief Financial Officer and a board member of Tier Technologies Inc. from February 1997 to January 2000, which became a public company during this period. Mr. Ross is a Certified Public Accountant and earned a Bachelor of Arts degree from Ohio Wesleyan University and a Masters of Business Administration from Ohio State University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014